Does anyone has any clue about how a treatment with monoclonal antibodies directed against a pathogen could lower the likelyhood of recurence of that infection? I guess it's through the activation of macrophage and NK cells through their Fc receptor, but what goes on downstream to build a memory for the next infection?
Online Survey Software powered by Cvent
Board Rules | advertise | Privacy
Copyright © 2004-2012 Scientist Solutions, All Rights Reserved.Resources from NCBI used on this site.